Testosterone Treatment Lawsuit Alleges Testim Caused Wrongful Death of Louisiana Man, Bernstein Liebhard LLP Reports

The Firm is evaluating Testosterone lawsuits on behalf of individuals who experienced life-threatening heart problems, allegedly due to Testim and other low-testosterone therapies.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friendRepost This
Free Case Review
Our Firm has heard from numerous men who allegedly suffered heart attacks, strokes, and other heart problems due to drugs like Testim. We are monitoring this growing litigation very closely.

New York, New York (PRWEB) April 14, 2014

Testosterone treatment lawsuits (http://www.testosteronelawsuitcenter.com/) are now being filed in courts around the country on behalf of men who allegedly suffered life-threatening heart problems due to prescription medications used to treat hypgonadism (low testosterone). According to court documents, the family of a Louisiana man recently filed a testosterone lawsuit that claims his fatal heart attack was caused by Testim, a medication he had used for approximately one year. The complaint, which was filed in the U.S. District Court, Eastern District of Louisiana on March 21, 2014, accuses Auxilium Pharmaceuticals, Inc. of selling a defective and unreasonably dangerous medication, and of engaging in aggressive marketing campaigns that misrepresented its safety.( Case 2:14-cv-00658)

“Our Firm has heard from numerous men who allegedly suffered heart attacks, strokes, and other heart problems due to drugs like Testim. We are monitoring this growing litigation very closely,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm is currently offering free legal reviews to anyone who may have suffered serious heart attacks, strokes, deep vein thrombosis or pulmonary embolism, allegedly due to the use of prescription testosterone therapies.

Testosterone Lawsuits
According to a Drug Safety Communication issued by the U.S. Food & Drug Administration (FDA) in January, a number of studies have linked the use of prescription testosterone therapies to life-threatening cardiovascular events, including heart attacks and strokes. The FDA is now conducting a safety review of these drugs, though it has not yet concluded that this class of medications can cause serious heart problems.

The studies that prompted the FDA to issue its safety communication included research that was published last November in the Journal of the American Medical System which reported an increased risk of heart attack, stroke and death among older men with pre-existing heart problems.* A second study, which was published in PLOS One in January, reported that such treatments ware associated with a doubling of the heart attack risk among younger men with pre-existing heart problems, and in men over 65 regardless of their heart health.**

Court documents indicate that at least 30 AndroGel lawsuits are currently pending in federal courts throughout the U.S. that claim that low testosterone therapy also caused men to suffer serious cardiovascular problems. On March 28th, plaintiffs in these lawsuits asked the U.S. Judicial Panel on Multidistrict Litigation to transfer all of these cases to the U.S. District Court, Northern District of Illinois for coordinated pretrial proceedings. (In Re: AndroGel Product Liability Litigation, No. 36, JPML)

Men who allegedly suffered serious heart side effects due to their use of prescription testosterone therapies may be entitled to compensation from the manufacturers of these drugs. To learn more about filing a testosterone treatment lawsuit, please visit Bernstein Liebhard LLP’s website. Free, no-obligation legal consultations can be obtained by calling 800-511-5092.

*jama.jamanetwork.com/article.aspx?articleid=1764051, JAMA, November 2013
**plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0085805, PLOS One, January 2014

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since the list was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com
http://www.testosteronelawsuitcenter.com/
https://plus.google.com/115936073311125306742?rel=author